In conclusion, these studies indicate that the NLRP3 inflammasome may affect renal fibrosis via the intestine-renal axis and the interaction between intestinal microbiota, presenting additional potential avenues for CKD treatment. This evidence concerns the gene NLRP3 and chronic kidney disease.